Medexus Pharmaceuticals Inc.

TSXV Exchange | Aug 5, 2020, 6:20 PM EDT | Real-time price

MDP $ 4.10 RT
0.10 (2.50%)
Day Low: 3.92
Day High: 4.10
Detailed Quote
Open: 3.96
High: 4.10
Beta: 1.2534
Shares Out.: 14,452,154
Total Shares (All Classes)2: 14,452,154
Prev. Close: 4.00
Low: 3.92
VWAP: 3.9879
Escrow Shares: 0
Market Cap (All Classes)2*: 59,253,831
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 14,452,154
EPS: -0.44
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 1.723
Market Cap1: 59,253,831
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action. More

News Headlines for Medexus Pharmaceuticals Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links

Note: as part of an update to TMX Money, this link will be removed on June 30, 2020. Users wishing to access InfoTSXV can continue to do so directly

News Headlines for Medexus Pharmaceuticals Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.